1. Seasonal influenza activity remains low nationally, with low levels of both outpatient illness and positive tests in clinical laboratories.
2. Influenza A and B viruses are co-circulating, with Influenza B viruses being the most frequently reported in public health laboratories.
3. There have been 152 reported influenza-associated pediatric deaths during the 2022-2023 season.
4. Hospitalization rates for influenza remain low, but rates are highest among adults aged 65 and older.
5. Pneumonia and influenza (P&I) mortality rates are above the epidemic threshold, indicating increased mortality due to these respiratory illnesses.
6. The majority of influenza viruses tested are similar to the strains included in the current influenza vaccine, and antiviral medications are generally effective against circulating strains.
7. Recommendations for annual influenza vaccination and the use of antiviral drugs for treatment are reiterated by the CDC.
8. Outpatient ILI activity remains below the national baseline, although there are some jurisdictions with moderate or high activity.
9. Long-term care facilities continue to report a low percentage of influenza-positive tests among residents.
10. FluView Interactive and additional international and state-level surveillance resources provide more detailed and localized information on influenza activity.